MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income
$2,224K
(-11.46%↓ Y/Y)
Other income
(expense), net
$89K
Collaboration agreements
$11,620K
Gain on termination
of collaboration...
$3,257K
Gain on sale of
technology and other assets
$130K
Total other income,
net
$2,272K
(-7.30%↓ Y/Y)
Income (gain) from
operations
$1,131K
(103.11%↑ Y/Y)
Realized and unrealized
(gain) loss on foreign...
-$41K
(-115.79%↓ Y/Y)
Total operating
expenses
$13,876K
(-61.85%↓ Y/Y)
Income (gain) before
income taxes
$3,403K
(110.03%↑ Y/Y)
Unrealized loss (gain) on
available-for-sale marketable...
$22K
(-91.97%↓ Y/Y)
Research and
development, net of tax...
$7,502K
(-73.59%↓ Y/Y)
General and
administrative
$4,548K
(-29.42%↓ Y/Y)
Restructuring
$1,826K
(19.58%↑ Y/Y)
Net income (gain)
$3,258K
(109.47%↑ Y/Y)
Total other
comprehensive income (gain)
$22K
(-91.97%↓ Y/Y)
Income tax expense
$145K
(-70.10%↓ Y/Y)
Comprehensive income (gain)
$3,280K
(109.61%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Repare Therapeutics Inc. (RPTX)
Repare Therapeutics Inc. (RPTX)